Drug Profile
Ondansetron/rizatriptan oral transmucosal film
Alternative Names: MSRX-202; Rizatriptan/ondansetronLatest Information Update: 22 Jan 2018
Price :
$50
*
At a glance
- Originator MonoSol Rx
- Developer Aquestive Therapeutics
- Class Antiemetics; Antimigraines; Carbazoles; Imidazoles; Small molecules; Triazoles; Tryptamines
- Mechanism of Action Serotonin 1B receptor agonists; Serotonin 1D receptor agonists; Serotonin 3 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Migraine; Nausea
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for phase-I development in Migraine(In volunteers) in USA (Transmucosal, Film)
- 04 Nov 2017 No recent reports of development identified for phase-I development in Nausea(In volunteers) in USA (Transmucosal, Film)
- 12 Feb 2015 Clinical development is ongoing in the US